[Organotypic spinal cord culture using mice]

Area of Science:

• Neuroscience
• Neurodegenerative Diseases

Context:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons.
• Current in vitro models, like rat spinal cord slice cultures, are used for preclinical ALS drug screening.
• Glutamate excitotoxicity is a key factor in motor neuron degeneration in ALS.

Purpose:

• To establish a modified organotypic mouse spinal cord slice culture as an alternative in vitro model for amyotrophic lateral sclerosis (ALS).
• To investigate the effects of L-trans pyrrolidine 2, 4-dicarboxylic acid (PDC) on motoneuron survival in the mouse spinal cord slice model.
• To enable the use of genetically modified mice (transgenic and knockout) for ALS research.

Summary:

• A novel mouse spinal cord slice culture model was developed, utilizing L-trans pyrrolidine 2, 4-dicarboxylic acid (PDC) to induce slow motoneuron loss via glutamate toxicity.
• This model selectively affects anterior horn motoneurons, preserving posterior horn neurons, and allows for the use of transgenic and knockout mouse lines.
• Ongoing efforts aim to create an improved in vitro ALS model using transgenic mice that exhibit spontaneous motor neuron degeneration.

Impact:

• Provides a valuable in vitro tool for preclinical drug screening and research into amyotrophic lateral sclerosis.
• Facilitates the study of genetically engineered mouse models, advancing the understanding of ALS pathogenesis.
• Contributes to the development of more effective therapeutic strategies for ALS by offering a refined experimental system.